There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Somatostatin-based radiopeptide treatment is generally performed using the β-emitting
radionuclides (90)Y or (177)Lu. The present study aimed at comparing benefits and
harms of both therapeutic approaches.